Compound Detail
CHEMBL445
NORTRIPTYLINE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL445 |
| Name | NORTRIPTYLINE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | PHVGLTMQBUFIQQ-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
42
Targets
99
Activities
2
Assay Types
23
PK Parameters
20
Publications
13
Known Names
12
Indications
Molecular Properties
263.4
MW (Da)
3.83
ALogP
1
HBA
1
HBD
12.0
PSA (Ų)
0.83
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1964 |
| Availability | Prescription |
| Chirality | Achiral |
Indications
Depressive Disorder Depressive Disorder Anxiety Dementia Dyspepsia Gastroesophageal Reflux Gastroparesis Schizophrenia Irritable Bowel Syndrome Psoriasis Temporomandibular Joint Disorders Tobacco Use Disorder
ATC Classification
N06AA10
nortriptyline
Level 1: NERVOUS SYSTEM
Level 2: PSYCHOANALEPTICS
Activity Summary
IC50 64 meas. best 10.4
Ki 35 meas. best 8.5
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Alpha-1A adrenergic receptor CHEMBL319 | IC50 | 10.4 | 8.46 | 0.0 | 2 |
| Histamine H1 receptor CHEMBL4701 | IC50 | 10.3 | 10.3 | 0.1 | 1 |
| Sodium-dependent noradrenaline transporter CHEMBL222 | Ki | 8.5 | 8.35 | 3.2 | 2 |
| Sodium-dependent noradrenaline transporter CHEMBL222 | IC50 | 8.49 | 8.49 | 3.2 | 1 |
| Histamine H1 receptor CHEMBL231 | Ki | 8.23 | 8.23 | 5.9 | 1 |
| Sodium-dependent serotonin transporter CHEMBL228 | Ki | 8.16 | 8.16 | 7.0 | 1 |
| Rattus norvegicus CHEMBL376 | IC50 | 8.15 | 6.925 | 7.0 | 2 |
| 5-hydroxytryptamine receptor 2C CHEMBL225 | Ki | 8.09 | 8.09 | 8.2 | 1 |
| Unchecked CHEMBL612545 | IC50 | 8.05 | 5.6614 | 9.0 | 7 |
| Muscarinic acetylcholine receptor M4 CHEMBL1821 | Ki | 7.89 | 7.89 | 13.0 | 1 |
| Sodium-dependent serotonin transporter CHEMBL228 | IC50 | 7.89 | 7.89 | 13.0 | 1 |
| 5-hydroxytryptamine receptor 2A CHEMBL224 | Ki | 7.82 | 7.82 | 15.0 | 1 |
| 5-hydroxytryptamine receptor 2C CHEMBL225 | IC50 | 7.8 | 7.8 | 16.0 | 1 |
| Muscarinic acetylcholine receptor M5 CHEMBL2035 | Ki | 7.7 | 7.7 | 20.0 | 1 |
| Muscarinic acetylcholine receptor M1 CHEMBL216 | Ki | 7.7 | 7.7 | 20.0 | 1 |
| Muscarinic acetylcholine receptor M5 CHEMBL2035 | IC50 | 7.57 | 7.57 | 27.0 | 1 |
| Alpha-2C adrenergic receptor CHEMBL1916 | Ki | 7.52 | 7.52 | 30.0 | 1 |
| Muscarinic acetylcholine receptor M3 CHEMBL245 | Ki | 7.44 | 7.44 | 36.0 | 1 |
| Alpha-2B adrenergic receptor CHEMBL1942 | Ki | 7.37 | 7.37 | 43.0 | 1 |
| Histamine H1 receptor CHEMBL231 | IC50 | 7.3 | 7.3 | 50.0 | 1 |
| 5-hydroxytryptamine receptor 2A CHEMBL224 | IC50 | 7.29 | 7.29 | 51.0 | 1 |
| D(3) dopamine receptor CHEMBL234 | Ki | 7.21 | 7.21 | 61.0 | 1 |
| Muscarinic acetylcholine receptor M1 CHEMBL216 | IC50 | 7.09 | 7.09 | 82.0 | 1 |
| 5-hydroxytryptamine receptor 2B CHEMBL1833 | Ki | 7.07 | 7.07 | 86.0 | 1 |
| Alpha-2B adrenergic receptor CHEMBL1942 | IC50 | 7.03 | 7.03 | 94.0 | 1 |
| Muscarinic acetylcholine receptor M4 CHEMBL1821 | IC50 | 7.02 | 7.02 | 95.0 | 1 |
| Alpha-1B adrenergic receptor CHEMBL315 | Ki | 6.94 | 6.94 | 114.0 | 1 |
| Muscarinic acetylcholine receptor M2 CHEMBL211 | Ki | 6.91 | 6.91 | 123.0 | 1 |
| Alpha-1A adrenergic receptor CHEMBL319 | Ki | 6.91 | 6.91 | 123.0 | 1 |
| 5-hydroxytryptamine receptor 2B CHEMBL1833 | IC50 | 6.87 | 6.87 | 136.0 | 1 |
| Alpha-1D adrenergic receptor CHEMBL223 | Ki | 6.87 | 6.87 | 134.0 | 1 |
| Serotonin (5-HT) receptor CHEMBL2094123 | IC50 | 6.77 | 6.77 | 170.0 | 1 |
| Muscarinic acetylcholine receptor M3 CHEMBL245 | IC50 | 6.77 | 6.77 | 171.0 | 1 |
| D(3) dopamine receptor CHEMBL234 | IC50 | 6.75 | 6.75 | 179.0 | 1 |
| Alpha-2C adrenergic receptor CHEMBL1916 | IC50 | 6.69 | 6.69 | 203.0 | 1 |
| Alpha-1B adrenergic receptor CHEMBL315 | IC50 | 6.68 | 6.68 | 207.0 | 1 |
| 5-hydroxytryptamine receptor 6 CHEMBL3371 | Ki | 6.67 | 6.63 | 214.0 | 2 |
| D(1A) dopamine receptor CHEMBL2056 | Ki | 6.57 | 6.57 | 269.0 | 1 |
| Alpha-2A adrenergic receptor CHEMBL1867 | Ki | 6.56 | 6.56 | 275.0 | 1 |
| Alpha-1D adrenergic receptor CHEMBL223 | IC50 | 6.56 | 6.56 | 273.0 | 1 |
| Unchecked CHEMBL612545 | Ki | 6.55 | 5.5788 | 280.0 | 8 |
| Muscarinic acetylcholine receptor M2 CHEMBL211 | IC50 | 6.46 | 6.46 | 347.0 | 1 |
| Mus musculus CHEMBL375 | IC50 | 6.3 | 5.735 | 500.0 | 2 |
| Plasmodium falciparum CHEMBL364 | IC50 | 6.3 | 6.27 | 500.0 | 2 |
| D(1A) dopamine receptor CHEMBL2056 | IC50 | 6.27 | 6.27 | 539.0 | 1 |
| 5-hydroxytryptamine receptor 6 CHEMBL3371 | IC50 | 6.26 | 6.26 | 554.0 | 1 |
| Alpha-2A adrenergic receptor CHEMBL1867 | IC50 | 6.13 | 6.13 | 732.0 | 1 |
| Cytochrome P450 2D6 CHEMBL289 | IC50 | 6.0 | 5.74 | 1000.0 | 3 |
| 5-hydroxytryptamine receptor 1A CHEMBL273 | Ki | 5.97 | 5.97 | 1068.0 | 1 |
| Trypanosoma brucei rhodesiense CHEMBL612348 | IC50 | 5.93 | 5.93 | 1170.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 10.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 9.8 | mL.min-1.kg-1 | Homo sapiens |
| CL | 10.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 10.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 144.0 | uL.min-1.(10^6cells)-1 | Rattus norvegicus |
| CL | 3.0 | mL.min-1.g-1 | Homo sapiens |
| F | 79.0 | % | Homo sapiens |
| Fu | 0.12 | - | Homo sapiens |
| Fu | 0.12 | - | Homo sapiens |
| Fu | 0.12 | - | Homo sapiens |
| Fu | 0.006 | - | Homo sapiens |
| Fu | 0.0046 | - | Rattus norvegicus |
| Fu | 0.004 | - | Sus scrofa |
| Fu | 0.009 | - | Macaca fascicularis |
| Fu | 0.007 | - | Canis lupus familiaris |
| Fu | 0.006 | - | Cavia porcellus |
| Fu | 0.008 | - | Mus musculus |
| Fu | 0.005 | - | Rattus norvegicus |
| Fu | 0.007 | - | Rattus norvegicus |
| MRT | 37.0 | hr | Homo sapiens |
| T1/2 | 35.5 | hr | - |
| T1/2 | 30.0 | hr | Homo sapiens |
| Vd | 35.0 | L.kg-1 | - |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL3885881 | Rattus norvegicus | 467 |
| 19378992 | 10.1021/jm900143u | Mus musculus | 23 |
| 16472241 | 10.2174/1570163043334794 | Hepatotoxicity | 18 |
| 22194678 | 10.1371/journal.pcbi.1002310 | Hepatotoxicity | 14 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | Unchecked | 11 |
| 20070106 | 10.1021/jm901371v | Homo sapiens | 8 |
| 6167716 | 10.1021/jm00135a006 | ADMET | 8 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | NON-PROTEIN TARGET | 8 |
| 10447960 | 10.1021/jm9910369 | ADMET | 5 |
| 21474681 | 10.1124/dmd.111.038778 | Brain | 5 |
| 18426954 | 10.1124/dmd.108.020479 | ADMET | 4 |
| 19256501 | 10.1021/jm801441s | No relevant target | 4 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 4 |
| - | 10.6019/CHEMBL3301361 | ADMET | 4 |
| 2966246 | 10.1021/jm00400a005 | Mus musculus | 4 |
| 6167716 | 10.1021/jm00135a006 | No relevant target | 4 |
| 20014752 | 10.1021/tx900326k | Hepatotoxicity | 3 |
| 9240356 | 10.1021/jm9603781 | Trypanothione reductase | 3 |
| 3373495 | 10.1021/jm00401a031 | Mus musculus | 3 |
| 10447960 | 10.1021/jm9910369 | Unchecked | 3 |
Data from ChEMBL 36 via Core Engine